One Assay. Genome + Methylome. At a Lower Cost.
A cost-effective 5-base approach to whole-genome methylation
The South Australian Genomics Centre (SAGC) has expanded its epigenomics capabilities with the introduction of Watchmaker Genomics TAPS+ whole-genome methylation sequencing, providing researchers with a new approach to studying DNA methylation and genetic variation together at whole-genome scale at approximately 30% lower cost than comparable 5-base whole-genome approaches.
Making larger methylation studies more accessible

DNA methylation adds an important layer of information beyond the four bases of the genome. By measuring A, T, G, C and 5mC, 5-base sequencing can provide an integrated view of genetic variation and DNA methylation across the genome.
The Watchmaker DNA Library Prep Kit with TAPS+ (distributed by TrendBio in Australia) uses a positive-readout approach that converts methylated cytosines while preserving unmethylated cytosines.
By retaining much more of the native four-base sequence complexity, TAPS+ supports efficient genome alignment and enables genomic variant analysis alongside genome-wide methylation detection.
From the same library, researchers can investigate:
- Genome-wide 5mC DNA methylation
- Single nucleotide variants (SNVs)
- Insertions and deletions
- Copy-number variation
- Relationships between genetic variation and epigenetic regulation
This dual-omics approach is particularly valuable for studies seeking to understand how variation in the underlying genome interacts with epigenetic regulation
Whole-genome discovery without predefined targets
DNA methylation is an important layer of epigenetic regulation involved in gene expression, development, ageing and disease. Whole-genome methylation sequencing provides the opportunity to investigate these patterns without restricting analysis to a predetermined panel of CpG sites.
TAPS+ takes a different approach from conventional methylation sequencing. Rather than converting unmethylated cytosines, its positive-readout chemistry selectively converts methylated cytosines (5mC) while preserving unmethylated cytosines. This retains much more of the native four-base sequence complexity and avoids the DNA damage associated with traditional bisulfite conversion.
→ Visit the Watchmaker Genomics website (TrendBio - Australian Distributor)
→ News article: Two Omics, One Library - TAPS+ and DNBSEQ evaluation demonstrated dual-omics capability, with SNP calling performed alongside methylation analysis from the same TAPS+ libraries.
Resources
→ View SAGC & TrendBio TAPS+ Brochure overview of performance data and a summary of key features and benefits.
Applications across biomedical research
Whole-genome TAPS+ sequencing can support a broad range of epigenomics research, including:
-
- Cancer epigenomics and tumour profiling
- Ageing and epigenetic clock research
- Population-scale methylation studies
- Biomarker discovery
- FFPE and archival tissue cohorts
- Developmental biology
- Neuroscience
- Integrated genetic and epigenetic studies
For Research Use Only. Not for use in diagnostic procedures.
Interested in discussing our Methyl-seq services?
Contact the SAGC to learn more about our services or ask about pricing -SAGC can assist with project planning, experimental design, sequencing, bioinformatics, and downstream data analysis.
